161 related articles for article (PubMed ID: 30739436)
21. Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time.
Kleer CG; Appelman HD
Am J Surg Pathol; 1998 Aug; 22(8):983-9. PubMed ID: 9706978
[TBL] [Abstract][Full Text] [Related]
22. Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis.
Olsen T; Rismo R; Gundersen MD; Paulssen EJ; Johnsen K; Kvamme JM; Goll R; Florholmen J
Cytokine; 2016 Mar; 79():90-5. PubMed ID: 26775117
[TBL] [Abstract][Full Text] [Related]
23. Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis.
Xu J; Tam M; Samaei S; Lerouge S; Barralet J; Stevenson MM; Cerruti M
Acta Biomater; 2017 Jan; 48():247-257. PubMed ID: 27769943
[TBL] [Abstract][Full Text] [Related]
24. Severe diffuse duodenitis successfully treated with intravenous tacrolimus after colectomy for ulcerative colitis.
Saito K; Katsuno T; Nakagawa T; Minemura S; Oyamada A; Kanogawa N; Saito M; Yoshihama S; Maruoka D; Matsumura T; Arai M; Tohma T; Miyauchi H; Matsubara H; Yokosuka O
Intern Med; 2014; 53(21):2477-81. PubMed ID: 25366006
[TBL] [Abstract][Full Text] [Related]
25. Ulcerative colitis endoscopic index of severity is associated with long-term prognosis in ulcerative colitis patients treated with infliximab.
Saigusa K; Matsuoka K; Sugimoto S; Arai M; Kiyohara H; Takeshita K; Mizuno S; Mori K; Nanki K; Takeshita T; Nakazato Y; Yajima T; Naganuma M; Hisamatsu T; Ogata H; Iwao Y; Kanai T
Dig Endosc; 2016 Sep; 28(6):665-70. PubMed ID: 26997640
[TBL] [Abstract][Full Text] [Related]
26. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and prognosis of patients with ulcerative colitis that shows rectal sparing at initial diagnosis.
Choi YS; Kim JK; Kim WJ
World J Gastrointest Endosc; 2021 Sep; 13(9):407-415. PubMed ID: 34630890
[TBL] [Abstract][Full Text] [Related]
28. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.
Krugliak Cleveland N; Rubin DT; Hart J; Weber CR; Meckel K; Tran AL; Aelvoet AS; Pan I; Gonsalves A; Gaetano JN; Williams KM; Wroblewski K; Jabri B; Pekow J
Clin Gastroenterol Hepatol; 2018 Jan; 16(1):68-74. PubMed ID: 28756053
[TBL] [Abstract][Full Text] [Related]
29. Pharmacotherapy of ulcerative colitis - current status and emerging trends.
Ahmad H; Kumar VL
J Basic Clin Physiol Pharmacol; 2018 Nov; 29(6):581-592. PubMed ID: 30089097
[TBL] [Abstract][Full Text] [Related]
30. Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm.
Johnsen KM; Goll R; Hansen V; Olsen T; Rismo R; Heitmann R; Gundersen MD; Kvamme JM; Paulssen EJ; Kileng H; Johnsen K; Florholmen J
Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):98-104. PubMed ID: 27749779
[TBL] [Abstract][Full Text] [Related]
31. New cell therapy using bone marrow-derived stem cells/endothelial progenitor cells to accelerate neovascularization in healing of experimental ulcerative colitis.
Deng X; Szabo S; Chen L; Paunovic B; Khomenko T; Tolstanova G; Tarnawski AS; Jones MK; Sandor Z
Curr Pharm Des; 2011; 17(16):1643-51. PubMed ID: 21548863
[TBL] [Abstract][Full Text] [Related]
32. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and clinical course of ulcerative gastroduodenal lesion associated with ulcerative colitis: possible relationship with pouchitis.
Hisabe T; Matsui T; Miyaoka M; Ninomiya K; Ishihara H; Nagahama T; Takaki Y; Hirai F; Ikeda K; Iwashita A; Higashi D; Futami K
Dig Endosc; 2010 Oct; 22(4):268-74. PubMed ID: 21175478
[TBL] [Abstract][Full Text] [Related]
34. Tracheobronchitis in ulcerative colitis: a case report of therapeutic response with infliximab and review of the literature.
Horgan L; Mulrennan S; D'Orsogna L; McLean-Tooke A
BMC Gastroenterol; 2019 Nov; 19(1):171. PubMed ID: 31675916
[TBL] [Abstract][Full Text] [Related]
35. Intensified Infliximab Induction is Associated with Improved Response and Decreased Colectomy in Steroid-Refractory Paediatric Ulcerative Colitis.
Church PC; Ho S; Sharma A; Tomalty D; Frost K; Muise A; Walters TD; Griffiths AM
J Crohns Colitis; 2019 Aug; 13(8):982-989. PubMed ID: 30715240
[TBL] [Abstract][Full Text] [Related]
36. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
[TBL] [Abstract][Full Text] [Related]
37. Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis.
Papamichael K; Van Stappen T; Vande Casteele N; Gils A; Billiet T; Tops S; Claes K; Van Assche G; Rutgeerts P; Vermeire S; Ferrante M
Clin Gastroenterol Hepatol; 2016 Apr; 14(4):543-9. PubMed ID: 26681486
[TBL] [Abstract][Full Text] [Related]
38. Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis.
Ierardi E; Giorgio F; Zotti M; Rosania R; Principi M; Marangi S; Della Valle N; De Francesco V; Di Leo A; Ingrosso M; Panella C
J Clin Pathol; 2011 Nov; 64(11):968-72. PubMed ID: 21945924
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis.
Farkas K; Rutka M; Golovics PA; Végh Z; Lovász BD; Nyári T; Gecse KB; Kolar M; Bortlik M; Duricova D; Machkova N; Hruba V; Lukas M; Mitrova K; Malickova K; Bálint A; Nagy F; Bor R; Milassin Á; Szepes Z; Palatka K; Lakatos PL; Lukas M; Molnár T
J Crohns Colitis; 2016 Nov; 10(11):1273-1278. PubMed ID: 27106537
[TBL] [Abstract][Full Text] [Related]
40. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
